Company / Inventory
NeoGenomics Laboratories, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$28.6M
FY2025
5-year range
$23.4M / $28.6M
FY2021-FY2025
Trend
+6.8%
vs FY2024
Sector context
#97 of 115
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s inventory of $29M is lower than 84% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 10 years, ranging from $6M in FY2016 to $30M in FY2020.
Based on SEC 10-K filings.
$29M in FY2025 with a 5-year CAGR of -0.7%.
Improved from $24M to $29M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +5.6%
- 5-Year CAGR
- -0.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 115This company $28.6M Sector average $1.4B
▼
-98.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.7%, indicating a declining trend.
- In FY2025, inventory increased 6.8% year-over-year.
- Ranks #97 out of 115 companies in the Health Care sector.
- Peak inventory was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.6M | +6.8% |
| FY2024 | $26.7M | +10.7% |
| FY2023 | $24.2M | -0.5% |
| FY2022 | $24.3M | +3.8% |
| FY2021 | $23.4M | -20.8% |
| FY2020 | $29.5M | +105.0% |
| FY2019 | $14.4M | +66.5% |
| FY2018 | $8.7M | +15.7% |
| FY2017 | $7.5M | +19.5% |
| FY2016 | $6.3M | +22.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026